Biodelivery Sciences International reported $11.38M in EBIT for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Acelrx Pharmaceuticals ACRX:US $ -8633000 1.05M
Adamas Pharmaceuticals ADMS:US -5636000 3.52M
Agile Therapeutics AGRX:US $ -15774000 877K
Biocryst Pharmaceuticals BCRX:US $ -44584000 15M
Cti Biopharma CTIC:US $ -23381000 3.88M
Daiichi Sankyo 4568:JP 38.97B 6.8B
Depomed DEPO:US $ 5.93M 17.93M
Endo International Ordinary Shares ENDP:US $ 207.28M 11.74M
JAZZ PHA JAZZ:US 28.37M 97.96M
Johnson & Johnson JNJ:US $ 7033M 2723M
Knight Therapeutics Inc GUD:CN C$ 4.02M 3.88M
Lannett LCI:US $ -8148000 3.21M
Mannkind MNKD:US $ -8552000 479K
Nektar Therapeutics NKTR:US $ -113596000 3.39M
Pacira Pharmaceuticals PCRX:US $ 30.72M 4.27M
Pfizer PFE:US $ 9254M 2592M
Redhill Biopharma RDHL:US -17398000 7.49M
Revance Therapeutics RVNC:US $ -72723000 2.39M
Teva Pharmaceutical TEVA:IT 806M 23M